Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Bioconjug Chem
2010 Aug 18;218:1455-64. doi: 10.1021/bc100050s.
Show Gene links
Show Anatomy links
GABAC receptor binding of quantum-dot conjugates of variable ligand valency.
Gussin HA, Tomlinson ID, Muni NJ, Little DM, Qian H, Rosenthal SJ, Pepperberg DR.
???displayArticle.abstract???
Highly fluorescent CdSe quantum dots (qdots) can serve as a platform for tethering multiple copies of a receptor-targeted ligand, affording study of how the level of multivalency affects receptor binding. We previously showed that qdots conjugated with long PEG chains terminated by muscimol, a known GABA(C) agonist, exhibit specific binding to the surface membrane of GABA(C) receptor-expressing Xenopus oocytes. The present report addresses the effect of varying the number, i.e., valency, of muscimol- (M-) terminated PEG chains attached to the qdot on binding of the resulting conjugate to GABA(C) receptors. M-PEG-qdots of differing muscimol valency were prepared by conjugating AMP-CdSe/ZnS qdots with muscimol-terminated and methylamine-terminated PEG chains in proportions designed to yield varying percentages of muscimol-terminated chains among the total approximately 150-200 chains bound to the qdot. The investigated valencies represented 0%, approximately 25%, approximately 50%, and 100% loading with muscimol (preparations termed M-PEG-qdot0, M-PEG-qdot25, M-PEG-qdot50, and M-PEG-qdot100, respectively. Binding of a given conjugate to surface membranes of GABA(C) receptor-expressing oocytes was analyzed by quantitative fluorescence microscopy following defined incubation with approximately 30 nM of the conjugate. With 5-20 min incubation, the fluorescence signal resulting from incubation with M-PEG-qdot25 exceeded, by approximately 6-fold, the fluorescence level obtained with M-PEG-qdot preparations that lacked muscimol-terminated chains (M-PEG-qdot0). M-PEG-qdot50 yielded a net signal roughly similar to that of M-PEG-qdot25, and that produced by M-PEG-qdot100 exceeded, by approximately 30-50%, those for M-PEG-qdot25 and M-PEG-qdot50. The time course of changes in oocyte surface membrane fluorescence resulting from the introduction of and removal of M-PEG-qdots in the medium bathing the oocyte indicated only a modest dependence of both binding and wash-out kinetics on muscimol valency. The results demonstrate a dependence of the binding activity of the M-PEG-qdot conjugates on muscimol valency, presumably reflecting higher GABA(C) avidity and/or affinity of the muscimol at high valency, and provide insight on the interactions of membrane receptor proteins with qdot conjugates containing multiple copies of a receptor-targeting ligand.
Adamian,
Structural model of rho1 GABAC receptor based on evolutionary analysis: Testing of predicted protein-protein interactions involved in receptor assembly and function.
2009, Pubmed,
Xenbase
Adamian,
Structural model of rho1 GABAC receptor based on evolutionary analysis: Testing of predicted protein-protein interactions involved in receptor assembly and function.
2009,
Pubmed
,
Xenbase Amin,
Insights into the activation mechanism of rho1 GABA receptors obtained by coexpression of wild type and activation-impaired subunits.
1996,
Pubmed
,
Xenbase Anikeeva,
Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response.
2006,
Pubmed Bentzen,
Surface modification to reduce nonspecific binding of quantum dots in live cell assays.
2005,
Pubmed Biju,
Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications.
2008,
Pubmed Dahan,
Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking.
2003,
Pubmed Gestwicki,
Influencing receptor-ligand binding mechanisms with multivalent ligand architecture.
2002,
Pubmed Goldman,
Multiplexed toxin analysis using four colors of quantum dot fluororeagents.
2004,
Pubmed Gussin,
Binding of muscimol-conjugated quantum dots to GABAC receptors.
2006,
Pubmed
,
Xenbase Jaiswal,
Imaging single events at the cell membrane.
2007,
Pubmed Krishnamurthy,
Dependence of effective molarity on linker length for an intramolecular protein-ligand system.
2007,
Pubmed Mason,
Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
2005,
Pubmed Medintz,
Quantum dot bioconjugates for imaging, labelling and sensing.
2005,
Pubmed Orndorff,
Quantum dot ex vivo labeling of neuromuscular synapses.
2008,
Pubmed Pathak,
Characterization of the functional binding properties of antibody conjugated quantum dots.
2007,
Pubmed Qian,
Molecular and pharmacological properties of GABA-rho subunits from white perch retina.
1998,
Pubmed
,
Xenbase Qian,
A comparison of GABAC and rho subunit receptors from the white perch retina.
1997,
Pubmed
,
Xenbase Rajan,
Ligand-bound quantum dot probes for studying the molecular scale dynamics of receptor endocytic trafficking in live cells.
2008,
Pubmed Robinson,
Probing lectin and sperm with carbohydrate-modified quantum dots.
2005,
Pubmed Rosenthal,
Targeting cell surface receptors with ligand-conjugated nanocrystals.
2002,
Pubmed
,
Xenbase Tomlinson,
Peptide-conjugated quantum dots: imaging the angiotensin type 1 receptor in living cells.
2005,
Pubmed Tomlinson,
Imaging GABAc receptors with ligand-conjugated quantum dots.
2007,
Pubmed
,
Xenbase Vu,
Activation of membrane receptors by a neurotransmitter conjugate designed for surface attachment.
2005,
Pubmed
,
Xenbase Willner,
Nanoparticle-enzyme hybrid systems for nanobiotechnology.
2007,
Pubmed
